Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01527591 · ClinicalTrials.gov registry record · NA
Pneumococcal Conjugate Vaccine 13 (Prevnar13®) in Children Who Are Solid Organ Transplant Recipients (SOT)
A NA study of Infection in Solid Organ Transplant Recipients, sponsored by University of California, Los Angeles.
- Active
- Registry status
- NA
- Development phase
- 17
- Enrollment target
- 1
- Study location
NCT01527591 is a NA study of Infection in Solid Organ Transplant Recipients that is active but no longer recruiting, run by University of California, Los Angeles. The registered enrollment target is 17 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01527591, a NA study of Infection in Solid Organ Transplant Recipients, is active but no longer recruiting, sponsored by University of California, Los Angeles.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the safety and long-term immunogenicity of the 13-Valent Pneumococcal Conjugate vaccine in children who are solid organ transplant recipients.
Conditions Studied
Interventions
- BIOLOGICAL Pneumococcal Conjugate Vaccine 13 (PCV13)
Study Locations (1)
California
- UCLA - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2012-02-01 |
| Est. Completion | 2025-12-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01527591
The ClinicalTrials.gov registry entry for NCT01527591 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Infection in Solid Organ Transplant Recipients appearing as the primary indexed condition, and to 1 intervention - of which Pneumococcal Conjugate Vaccine 13 (PCV13) is the first listed.
NCT01527591 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01527591 about?
NCT01527591 is a clinical study titled "Pneumococcal Conjugate Vaccine 13 (Prevnar13®) in Children Who Are Solid Organ Transplant Recipients (SOT)". The purpose of this study is to determine the safety and long-term immunogenicity of the 13-Valent Pneumococcal Conjugate vaccine in children who are solid organ transplant recipients.
What is the current status of trial NCT01527591?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 17 participants. The study started on 2012-02-01. Estimated completion is 2025-12-30.
What conditions does trial NCT01527591 study?
This clinical trial studies the following conditions: Infection in Solid Organ Transplant Recipients.
What interventions are being tested in trial NCT01527591?
The interventions under investigation include: Pneumococcal Conjugate Vaccine 13 (PCV13) (BIOLOGICAL).
Who is sponsoring clinical trial NCT01527591?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01527591 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infection in Solid Organ Transplant Recipients
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.